Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Fortune III who wrote (895)	5/21/1998 5:58:00 PM
From: Ray Tarke	Read Replies (2) \| Respond to of 2887

One of many Revolutionary Products - The OmniCath Atherectomy Catheter. The OmniCath is an atherectomy catheter, designed to allow physicians to remove atherosclerotic plaque from obstructed blood vessels throughout the body, enlarging the narrowed vessel openings and thereby restoring normal blood flow. The Company is developing the OmniCath with catheter shafts of several different diameters for use in coronary arteries which feed the heart (5.8 to 7 French) and in peripheral arteries in the abdomen, groin and legs (7 French and 8 French). "French" is a measure of diameter, one French is equivalent to 1/3rd of a millimeter. The OmniCath is self-contained and disposable and is powered by a small battery pack and motor assembly in the handle. Connected to the handle is the catheter shaft which will vary in length depending on the distance needed from insertion to the treatment site. The weight of the OmniCath is approximately 11 ounces. The OmniCath's shaft has a side-window and a small rotating cylindrical blade near its distal end (the end of the catheter or farthest part of the catheter which is inserted into the body). At the surface opposite the side-window are two deflector wires which, when advanced against the arterial wall opposite the plaque using controls in the handle, stabilize the catheter shaft and allow the window to cover a larger volume of the plaque, compressing it into the path of the rotating blade. Once the deflector wires are engaged and the side window is in position, using controls on the OmniCath handle, the rotating blade can be advanced and retracted across the side-window at approximately 11,000 RPM to shave the atherosclerotic plaque from the interior surface of the vessel walls. The blade does not come into contact with the non-diseased arterial walls during the atherectomy procedure. The shaved plaque is aspirated into an annular space in the catheter and evacuated through a removal port at the proximal end of the catheter (the end at the OmniCath handle) via a vacuum system. This enables the excised plaque to be collected and examined while the atherectomy is taking place. There is very little loss of blood during the procedure as the OmniCath is designed to restrict the amount of blood which enters the catheter system. Further, the blockage of blood circulation by an inflated balloon, which often occurs in balloon angioplasty, does not occur in a procedure using the OmniCath. The deflectable system which holds the catheter in place is designed to allow for continuous blood flow. This allows more time to complete a procedure although a procedure using the OmniCath should generally require less time than a procedure utilizing multiple balloon inflations to break up the plaque. As opposed to balloon angioplasty, which cracks and displaces plaque, the shaving mechanism of the OmniCath removes plaque and is designed to leave the artery clean and smooth, free of fissures, ruptures, and flaps. Overall, the OmniCath is designed for ease of use and provides the physician with the capability to multiple lesion atherectomy procedures with a single placement as opposed to the multiple placements often required with balloon angioplasty and competitive atherectomy devices. The OmniCath's features, including its lightweight and compact construction are designed to provide a competitive advantage over existing atherectomy catheters. The news Today ! biz.yahoo.com This news is Fantastic and how many in the medical arena such as J&J and many other would love to have this in there portfolio. Look at the String of great news one after another this company could be the "Deal of the Century" at this price you can make yourself rich, but the price is not going stay low for long. I am buying and waiting for this Baby ... brings in the Pot of Gold ! Regards, R.T